Navigation Links
AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell
Date:12/4/2009

HOUSTON, Dec. 4 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education course published by PennWell Corporation, a leader in professional education for many industries, including medicine and dentistry. The course focuses on patient views about orthodontic treatment, a summary of treatment biomechanics, factors that increase treatment duration, and the role that pulsatile forces can play in modulating periodontal biology and accelerating orthodontic treatment. The technology supporting the AcceleDent System involves the application of pulsatile forces. The course can be accessed directly through PennWell's dental education website http://www.ineedce.com/

(Photo: http://www.newscom.com/cgi-bin/prnh/20091204/DA21078)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that an orthodontic patient wears in the mouth for 20 minutes daily to accelerate orthodontic tooth movement. A Phase I clinical trial in 2008 in Houston, Texas demonstrated the safety of the device. The first case in private practice was initiated in October 2009 in the UK, following EU approval.

The course is a peer-reviewed publication titled "Advances in Orthodontic Treatment," and was authored by Jeremy J. Mao, DDS, PhD, who recently lectured internationally on the biological action of pulsatile force, and Chung H. Kau, DDS, MScD, MBA, PhD, MOrth, FDS, FFD (Ortho), FAMS (Ortho), who oversaw the Phase I clinical trial that featured the first use of the AcceleDent technology in patients at the University of Texas Dental Branch. The course is intended for orthodontists and dental professionals and awards 4 CE credits. PennWell is an ADA CERP (Continuing Education Recognition Program) provider.

Dr. Jeremy Mao observed, "We believe that a great deal of knowledge has been unveiled in recent years as it relates to pulsatile forces and biological response of alveolar bone. The scientific data have important implications in the rate of orthodontic treatment. This course is a timely opportunity to create awareness around these concepts." He continued, "The Phase I clinical trial conducted at the University of Texas Dental Branch represents scientific validation of years of animal data on the effectiveness of pulsatile forces." Brent Tarver, VP Clinical Affairs for the Company added, "OrthoAccel is committed to its investment in a clinical strategy that is ultimately intended to not only elaborate the scientific basis for AcceleDent, but also discover new ways to improve orthodontic care."

OrthoAccel is presently controlling availability of AcceleDent in the UK to a select group of orthodontic specialists before a broader release there in October 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com or requested via info@orthoaccel.com

Media Contact Michael K. Lowe, CEO +1 (832) 631-1659

About PennWell Corporation

PennWell Corporation is a diversified business-to-business media and information company that provides quality content and integrated marketing solutions for the following industries: Oil and gas, electric power, renewable energy, water, electronics, semiconductor, contamination control, optoelectronics, fiberoptics, enterprise storage, fire, emergency services and dental. Founded in 1910, PennWell publishes 75 print and online magazines and newsletters, conducts 60 conferences and exhibitions on six continents, and has an extensive offering of books, maps, web sites, research and database services. In addition to PennWell's headquarters in Tulsa, Oklahoma, the company has major offices in Nashua, New Hampshire; Houston, Texas; London, England; Fairlawn, New Jersey; Moscow, Russia; and Hong Kong, China. For additional information about PennWell, visit www.pennwell.com.

SOURCE OrthoAccel Technologies, Inc.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices
2. Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers
3. Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
4. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
5. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
6. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
7. Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
8. Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
9. Derma Sciences Files S-1 Registration Statement
10. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
11. Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/10/2017)... BESSEMER, Ala. , June 9, 2017  Shane K. Burchfield, ... Member recognized for excellence as a Podiatrist in Alabama ... of Podiatry at Family First Foot Care. He brings over 20 ... sports medicine, pain management and healthcare, to his role. ... Family First Foot Care, PC is pleased to welcome ...
(Date:6/8/2017)... , June 8, 2017  StatLab ... leading developer and manufacturer of diagnostic supplies ... today that Cressey & Company LP ("Cressey ... has completed a growth-focused investment in the ... majority ownership position from selling shareholder, Prairie ...
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy ... the United States . The Raizer is ... a fallen person up to an almost-standing position ... and operated by one assistant and does not ... is simple enough that a child can operate it, ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is ... Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases their ... title in 2015, this marks the 3rd time that Dr. Canales has ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... grant from the American Heart Association (AHA) to launch a Rheumatic Heart Disease ... the prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged ...
(Date:6/22/2017)... ... June 22, 2017 , ... Vighter, a premier ... received certification for ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, ... of law has been degraded. The PSC.1 standard was created to protect fundamental ...
(Date:6/20/2017)... Tennessee (PRWEB) , ... June 20, 2017 , ... ... care services, announced today that Claritas Capital, a Nashville-based private equity firm, has ... accelerate our expansion plans for some time, and Claritas Capital offers the smart ...
(Date:6/20/2017)... ... 2017 , ... After months of negotiations, FaceCradle USA is proud to announce the debut of ... , “Introducing our product on QVC is something we all worked hard to achieve for ... more than 90 million homes in the United States,” said FaceCradle USA President Dylan Doherty. ...
Breaking Medicine News(10 mins):